ADENOCOR

Brand name authorized in: Spain Ireland Lithuania Netherlands New Zealand Poland Singapore United Kingdom

Active ingredients

The drug ADENOCOR contains one active pharmaceutical ingredient (API):

1 Adenine Deoxy Nucleoside
UNII K72T3FS567 - ADENOSINE

Adenosine is a purine nucleoside which is present in all cells of the body. Animal pharmacology studies have in several species shown that adenosine has a negative dromotropic effect on the atrioventricular (AV) node.

Read about Adenine Deoxy Nucleoside

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Adenosine
C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EB Other cardiac preparations
Discover more medicines within C01EB10

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 60375
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 47447
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1090482, 1090617
NL
Z-Index G-Standaard
Identifier(s): 13822764
NL
Z-Index G-Standaard, PRK
Identifier(s): 39292
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 7021
PL
Rejestru Produktów Leczniczych
Identifier(s): 100002987, 100291980, 100346876, 100371489, 100424027, 100429645
SG
Health Sciences Authority
Identifier(s): 07679P